AstraZeneca (AZN)
(Delayed Data from NSDQ)
$78.38 USD
-0.52 (-0.66%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $78.50 +0.12 (0.15%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth D Momentum D VGM
Average Brokerage Rating
Current ABR | 1.70 |
ABR (Last week) | 1.70 |
# of Recs in ABR | 15 |
Average Target Price | $86.96 |
LT Growth Rate | 13.10% |
Industry | Large Cap Pharmaceuticals |
Industry Rank by ABR | 79 of 253 |
Current Quarter EPS Est: | 1.07 |
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 11 | 11 | 11 | 11 | 11 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 1 | 1 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 2 | 2 | 1 | 1 | 1 |
ABR | 1.70 | 1.70 | 1.57 | 1.57 | 1.57 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/16/2024 | UBS | Matthew Weston | Strong Sell | Strong Sell |
8/12/2024 | Cowen & Co. | Steve M Scala | Strong Buy | Strong Buy |
7/24/2024 | SVB Securities | Andrew Berens | Strong Buy | Strong Buy |
6/24/2024 | Not Identified | Not Identified | Not Available | Strong Buy |
6/24/2024 | Not Identified | Not Identified | Not Available | Strong Buy |
5/30/2024 | Goldman Sachs | Rajan Sharma | Not Available | Strong Buy |
5/8/2024 | Not Identified | Not Identified | Hold | Hold |
5/4/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
4/26/2024 | BMO Capital Markets | Etzer Darout | Strong Buy | Strong Buy |
3/15/2024 | Argus Research Corp. | Jasper Hellweg | Strong Buy | Strong Buy |
2/20/2024 | Berenberg Bank | Luisa Hector | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.